Cencora issues revised segment financial results for fiscal 2025 and 2026
Cencora reported revised revenue figures showing a 5.1% year-over-year increase across its Pharmaceutical Distribution and Specialty Services segments for fiscal year-ended September 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed